Assignee
KANCERA AB
SE12 patents
Top patents by PatentIndex Score
US11691988B2Jul 4, 2023
Process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines and products obtainable therefrom
KANCERA AB2 citations68
US10654814B2May 19, 2020
Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity
KANCERA AB5 citations68
US11339183B2May 24, 2022
Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1
KANCERA AB2 citations67
US12264165B2Apr 1, 2025
Process for the stereoselective preparation of chiral 2-[(hetero) arylalkylsulfanyl]pyrimidines and products obtainable therefrom
KANCERA AB0 citations58
US11542281B2Jan 3, 2023
Process for the steroselective preparation of chiral 2- [(hetero)arylalkylsulfanyl] pyrimidines and products obtainable therefrom
KANCERA AB0 citations58
US12060380B2Aug 13, 2024
Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1
KANCERA AB0 citations56
US11660303B2May 30, 2023
2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
KANCERA AB0 citations43
US11008318B2May 18, 2021
2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
KANCERA AB0 citations43
US10550113B2Feb 4, 2020
2-phenyl-3H-imidazo[4,5-B]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
KANCERA AB0 citations34
US10512634B2Dec 24, 2019
Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity
KANCERA AB0 citations34
US9718809B2Aug 1, 2017
Bisarylsulfonamides useful in the treatment of inflammation and cancer
KANCERA AB0 citations33
US10000449B2Jun 19, 2018
Bisarylsulfonamides useful in the treatment of inflammation and cancer
KANCERA AB0 citations30